# Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.

> PubMed lists PMID 42075085 in Nutrients as Journal Article, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42075085-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-16
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42075085-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42075085-tirzepatide-v1.json
- Content SHA-256: `2bea29382fe6949148e89e4fe060b71fbd1c0d15d1b6827bf0e2604931da5477`

## Claims and source pins

### Headline

Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome. ([`pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea`](#source-pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea))

### Summary

PubMed lists PMID 42075085 in Nutrients as Journal Article, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea`](#source-pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea))

### Paragraph 1

PubMed lists PMID 42075085 in Nutrients as Journal Article, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea`](#source-pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea`](#source-pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea))

## Sources

<a id="source-pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea"></a>
- **Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome. · retained source version 1:2026-07-16:current:b0a2ef558bea579f66d6855fb5f5ec4356393fc591f5218557d725856b6b5764** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42075085/) (`pubmed-observation-pmid-42075085-2026-07-16-b0a2ef558bea`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42075085-tirzepatide-v1.json SHA-256: 2bea29382fe6949148e89e4fe060b71fbd1c0d15d1b6827bf0e2604931da5477.